Warner-Lambert loses appeal at UK Supreme Court on validity of its patent for a second medical use of pregabalin for the treatment of pain
Earlier this week, the Supreme Court handed down its judgment in Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan and Actavis, holding Warner-Lambert’s patent to be invalid.